The Master of Biomedical Innovation (MBI) program is a multidisciplinary, project-oriented graduate program focused on bridging the gap between technology development and its transfer into local, national, and international biomedical markets.
By linking the theory and practice of the biomedical innovation process, the program delivers a systematic but responsive approach to the critical, emerging discipline of innovation and entrepreneurship (I&E).
You will learn how to create and market biomedical products or devices.
You will network and learn from renowned inventors and innovators.
You will better understand emerging opportunities in therapeutics, artificial intelligence (AI), medtech, and more.
The MBI is a one-year program with the curriculum divided into three phases guiding learners through the biomedical innovation
and entrepreneurship process.
Information Box Group
Term 1 - Biomedical problem identification and exploration
Term 2 - Solutions design and prototyping
Term 3 - Business model and pitch development
Learners will simultaneously acquire and apply the theories and skillsets presented across the three phases
to a year-long, venture-orientated project.
THE MBI IS UNIQUE WITHIN HEALTH SCIENCES EDUCATION AND IS THE
FIRST GRADUATE HEALTH-CARE ENTREPRENEURSHIP PROGRAM OF ITS KIND IN CANADA.
MBI Testimonials
The Marnix E. Heersink School of Biomedical Innovation and Entrepreneurship and the MBI program will be based in the Michael G. DeGroote Centre for Learning and Discovery. The new space is currently under construction and is expected to be completed early spring 2024. Follow us on social media (@machealthice) to see construction video updates.